The three preceding papers in this series identified a single broken step in a single cycle and proposed a single minimum intervention. Aging does not permit that simplicity. It is not a disease with a broken step — it is the thermodynamic consequence of broken steps in every biological system, accumulated over time. Every cycle that fails to complete leaves residue. Aging is that residue.
These failures share a common mediating failure: the progressive decline of the NAD⁺/sirtuin axis — the molecular machinery that enables the resolution step across most biological cycles simultaneously. As NAD⁺ declines (primarily through CD38-mediated depletion driven by accumulated senescent cells), resolution capacity degrades across all systems at once.
The minimum intervention is two steps in sequence: (1) clear the senescent cell burden driving NAD⁺ depletion; (2) restore NAD⁺ availability to re-enable sirtuin-dependent resolution. Clear the backlog. Restore the machinery. The cycles complete.
Aging manifests simultaneously as genomic instability, epigenetic drift, proteostasis failure, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and chronic low-grade inflammation. These are not independent — they interact, amplify each other, and share upstream mediators.
Aging is characterized by a broken resolution capacity — the shared machinery that enables many different cycles to complete. As this capacity degrades, DNA damage accumulates because repair is slower to complete; epigenetic state drifts because chromatin restoration is incomplete; damaged organelles accumulate because clearance cycles don't finish; senescent cells accumulate because they activated but could not resolve.
The minimum intervention for aging is not to restore a single signal but to restore the resolution machinery itself.
NAD⁺-dependent sirtuins are the molecular executors of the resolution step across multiple biological cycles:
| Sirtuin | Location | Resolution function |
|---|---|---|
| SIRT1 | Nucleus / cytoplasm | Restores chromatin state after repair; activates autophagy; activates mitochondrial biogenesis |
| SIRT3 | Mitochondria | ROS clearance; required for mitophagy completion |
| SIRT6 | Nucleus | Chromatin restoration at DNA damage sites; repair completion |
NAD⁺ declines approximately 50% between young adulthood and late age in most tissues. The decline is not primarily due to reduced biosynthesis — it is due to increased consumption by CD38, a NAD⁺ glycohydrolase induced by the inflammatory SASP of senescent cells.
Senescent cells (stalled cycles) → SASP (IL-6, TNF-α, MMPs) → CD38 upregulation in neighboring tissue → NAD⁺ depletion → Impaired sirtuin/PARP activity → Cycles stall at resolution step → More senescent cells → (repeat)
The loop is self-amplifying. A small number of early senescent cells initiates a cascade that progressively degrades resolution capacity across all tissue. Clearing the backlog without fixing the mechanism repeats indefinitely. The accumulations return.
Senolytics selectively induce apoptosis in senescent cells by targeting their dependency on anti-apoptotic pathways (BCL-2, BCL-XL) they upregulate to survive despite persistent DNA damage signaling.
Dasatinib + quercetin (D+Q): First clinically tested senolytic combination. Intermittent dosing is effective. Clinical trials show reduction in senescent cell markers and improvement in physical function in older adults.
Selective BCL-XL inhibitors: Next-generation compounds maintain senolytic activity with reduced thrombocytopenic side effects.
After senescent cell clearance, SASP-driven CD38 induction diminishes. NAD⁺ is then restored by:
CD38 inhibition (apigenin, 78c): Directly reduces NAD⁺ consumption. More targeted than supply-side supplementation — addresses the mechanism of depletion.
NAD⁺ precursor supplementation (NMN, NR): Elevates NAD⁺ in rodents and humans. Combined with CD38 inhibition for additive effect.
Senescent burden reduced → SASP diminished → CD38 downregulated → NAD⁺ restored → Sirtuin activity restored → DNA repair cycles complete → Epigenetic restoration cycles complete → Mitophagy cycles complete → New senescent cells cleared by restored NK/macrophage function → Cycle debt stops compounding
The system does not become young. The existing damage remains. But the rate of new cycle failure drops. The compounding stops.
| Condition | Broken step | Intervention |
|---|---|---|
| HIV | Resolution — no IL-10 | NFAT→IL-10 edit in T cells |
| Cancer | Checkpoint — no p53 stop | Base edit p53 hotspot mutations |
| Neurodegeneration | Clearance — TREM2 R47H | Base edit TREM2 R47H |
| Aging | Resolution capacity — NAD⁺/sirtuin decline | Senolysis → CD38 inhibition → NAD⁺ |
Aging is the meta-condition — the one that makes every other cycle repair harder over time. Aging interventions should precede or accompany disease-specific interventions, because restored resolution capacity amplifies the efficacy of every targeted repair.
Aging is accumulated cycle debt. Every biological system runs activation-resolution cycles. Every cycle that fails to complete leaves residue. Over a lifetime, this residue accumulates — not randomly, but concentrated around a shared failure point: the NAD⁺/sirtuin axis.
The minimum intervention is not to address each aging process separately. Clear the primary driver of resolution machinery failure. Restore the resolution machinery. After that, biology does the rest.
Not reversal. Restoration. The cycle runs again.
Camacho-Pereira, J., et al. (2016). CD38 dictates age-related NAD decline through an SIRT3-dependent mechanism. Cell Metabolism, 23(6), 1127–1139.
Hickson, L.T.J., et al. (2019). Senolytics decrease senescent cells in humans. EBioMedicine, 47, 446–456.
López-Otín, C., et al. (2013). The hallmarks of aging. Cell, 153(6), 1194–1217.
Mills, K.F., et al. (2016). Long-term administration of NMN mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806.
Verdin, E. (2015). NAD⁺ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208–1213.